Streetwise Articles
Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research
Source: Streetwise Reports (12/11/19)
Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-2020, and potential for a Marketing Authorization Application in 2021.
More >
Petroleum Firm Sells Assets to Focus on Montney Projects
Source: Streetwise Reports (12/11/19)
The details, finances and impact of the transaction are discussed in a CIBC report.
More >
A.I.S. Resources: A New Gold Prospect + Manganese Trading + Li Extraction Technology
Source: Peter Epstein for Streetwise Reports (12/11/19)
Peter Epstein of Epstein Research profiles a company that is reinventing itself as moderately diversified battery metals company.
More >
Company Extends REE Mineralization at Canada Project
Source: Streetwise Reports (12/10/19)
Consequently, additional drill testing is warranted in the specific host zone.
More >
Oil & Gas Firm Provides Update on Exploration Well
Source: Streetwise Reports (12/10/19)
Drill testing leads to decision to abandon the well.
More >
Silver: The HARD Look
Source: Michael Ballanger for Streetwise Reports (12/10/19)
Precious metals expert Michael Ballanger takes a look at the factors behind silver's recent price decline.
More >
Avid Bioservices' Shares Rise on Q2/20 Earnings and Confirmed Outlook
Source: Streetwise Reports (12/10/19)
Shares of Avid Bioservices traded higher today, reaching a new 52-week high, after the firm reported Q2/20 earnings and reaffirmed its revenue guidance for Full-Year 2020.
More >
Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's
Source: Streetwise Reports (12/10/19)
How this company's Alzheimer's therapeutic compares to an advanced-stage competitor is outlined in a Dawson James Securities note.
More >
Copper Company Closes 30% Share of Acquisition of Copper North Mining
Source: Streetwise Reports (12/9/19)
The two companies are advancing adjoining projects in the Yukon.
More >
ArQule Shares Double on Proposed $2.7 Billion Tender Offer from Merck
Source: Streetwise Reports (12/9/19)
ArQule Inc. shares traded more than 100% higher today after the company entered into definitive agreement to be acquired by a Merck subsidiary company for $20 per share. The deal is valued at $2.7 billion and is expected to close in the early part of Q1/20.
More >
Young Company Plans to Bring Mexican Gold Deposit to Market in Two Years
Source: Maurice Jackson for Streetwise Reports (12/9/19)
Andrew Bowering, president of Prime Mining, talks with Maurice Jackson of Proven and Probable about his company's plans to fast track its gold project.
More >
Company Reports 'Robust PEA' for South Dakota Uranium Project
Source: Streetwise Reports (12/7/19)
The report validates the Colorado-based company's strategy.
More >
Antibiotic Alternative for Livestock Feed Approved for Malaysia
Source: Streetwise Reports (12/7/19)
Now, the company has the green light to sell this product in eight countries.
More >
Explorer More Than Doubles Drill Campaign at Red Lake District Project
Source: Streetwise Reports (12/7/19)
The Canadian company announced a $21 million budget and aims to complete the expansion by year-end 2020.
More >
Explorer Gathers Data on Quebec Gold Property
Source: Streetwise Reports (12/6/19)
Regional geology, mineral showings, historical drill results and magnetic survey results are among the information obtained.
More >
Explorer Options Majority Interest in Gold Project
Source: Streetwise Reports (12/6/19)
Incubating and monetizing assets are among the company's strategic objectives.
More >
'High Potential' Targets Identified at Oaxaca Gold Project
Source: Streetwise Reports (12/6/19)
The gold-silver company continues to advance the asset.
More >
Imagin Medical Poised for Breakout with Bladder Cancer Detection Device
Source: Knox Henderson for Streetwise Reports (12/6/19)
A new advancement in bladder-related endoscopic surgery is endorsed and de-risked.
More >
Cassava Sciences' Shares Trade Up 20% on Updated Phase 2a Alzheimer's Data
Source: Streetwise Reports (12/6/19)
Shares of Cassava Sciences traded 20% higher after the firm presented additional data from the Phase 2a study of its investigational drug candidate PTI-125 for Alzheimer's disease to the Clinical Trials on Alzheimer's Disease conference in San Diego, Calif.
More >
'Huge Upside Potential' on Firm That Turns Plastic Waste into Synthetic Fuels
Source: Streetwise Reports (12/5/19)
The rationale for investing in this company is provided in a Pareto Securities report.
More >
Junior Explorer Moves Forward in 'Prime Gold Real Estate'
Source: Jay Taylor for Streetwise Reports (12/5/19)
Jay Taylor of J. Taylor's Gold, Energy & Tech Stocks examines the prospects of a company working in the exploration and development of Larder gold deposits along the Cadillac-Larder Lake Fault in Ontario.
More >
AR Tech Company Expands Deal with Manufacturer of James Bond PPK
Source: Streetwise Reports (12/5/19)
The firm will now provide its Web-based, three-dimensional, augmented reality service to the client.
More >
Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data
Source: Streetwise Reports (12/5/19)
Shares of Aurinia Pharmaceuticals traded much higher today after it reported positive results from its Phase 3 AURORA trial of Voclosporin for treatment of lupus nephritis. The company plans to submit a New Drug Application to the FDA in H1/20.
More >
Immuno-Oncology Firm Expands Agreement with AbbVie
Source: Streetwise Reports (12/4/19)
The revisions to the existing arrangement between the two U.S. firms are discussed in a ROTH Capital Partners report.
More >
Bitumen Resource Estimate Completed for Alberta Asset
Source: Streetwise Reports (12/4/19)
The report outlines a development plan for the project.
More >




